SIMPLY SOLVENTLESS PROVIDES Q3 2024 GUIDANCE INCLUDING RECORD PROJECTED QUARTERLY REVENUE AND EIGHTH STRAIGHT QUARTER OF NET INCOME PROFIT, AND ANNOUNCES UPCOMING PRODUCT LAUNCHES
/NOT FOR DISTRIBUTION TO
Adjusted EBITDA and normalized net income are non-IFRS measures. See Non-IFRS Financial Measures, below.
Q3 2024 Guidance
SSC projects record quarterly gross revenue during Q3 2024 of approximately
SSC projects Q3 2024 adjusted EBITDA of approximately
During Q3 2024 SSC has had slightly lower B2B and tolling revenue compared to Q2 2024 due to seasonality, as Q3 has historically lower B2B and tolling sales. This is expected to slightly reduce gross margins for Q3 2024. B2B and tolling revenue is expected to return to Q2 2024 levels during Q4 2024. SSC also expects that cost synergies related to the acquisition of
SSC's streak of positive adjusted EBITDA and normalized net income is expected to extend to ten and eight quarters respectively.
Year to Date (Nine Months Ended
On a year-to-date basis, SSC projects record gross revenue for the nine months ended
Upcoming Product Launches
SSC is pleased to announce that it is launching 27 new products in
-
Astrolab Launching
October 2024 :- Astrolab Galactic Sour Live Rosin Star Solventless Gummies.
- Astrolab Galactic Sweet Live Rosin Star Solventless Gummies.
Astro Sampler 3-Pack Live Rosin Infused Pre-rolls.- Astrolab Squirt 90-189u Premium Cold Cure Live Rosin.
- Astrolab Banjo 90-189u Premium Cold Cure Live Rosin.
-
Astrolab Launching
November 2024 :- Astrolab Interstellar Live Rosin Cream Soda.
- Astrolab Interstellar
Rocket Lime Live Rosin Soda . - Astrolab Summer Cherry Punch Live Rosin Infused Pre-rolls.
-
Frootyhooty Launching
October 2024 :- Frootyhooty Poppin' Peach Full Spectrum Loops.
- Frootyhooty Wild Watermelon Coconut Full Spectrum Wedges.
- Frootyhooty Pink Lemonade Full Spectrum Sours.
-
Frootyhooty Launching
November 2024 :- Frootyhooty Pink Lemonade Diamonds & Live Rosin Sauce.
- Frootyhooty Pink Lemonade Distillate + Live Rosin 510 vape cart 1g.
- Frootyhooty Pink Lemonade Distillate + Live Rosin Disposable 1g.
-
Roilty Launching
October 2024 :- Roil
Lemon Haze Shatter .
- Roil
-
Roilty Launching
November 2024 :- Roil Indica Live Resin Reserve Disposable Vape.
- Roil Sativa Live Resin Reserve Disposable Vape.
- Roil Sunrise
Sativa Shatter . - Roil Sunset
Indica Shatter .
-
Lamplighter Launching
October 2024 :- Honeydew Lime Prefilled Vape Cartridge.
-
Lamplighter Launching
November 2024 :- Lamplighter Tiger Berry Liquid Diamond Dabber.
-
Uncommon Cannabis Launching
November 2024 :- Uncommon Mango Crush.
- Uncommon Dream Catcher.
- Uncommon Pink Ghost.
- Uncommon White Hot Guava.
-
Rilaxe Launching
November 2024 :- Rilaxe Ménage à Trois 3x0.7g.
- Rilaxe Morning Sex 1x1g.
SSC is also pleased to announce the following two products that are being launched in
- Astrolab Interstellar Live Rosin Cream Soda.
- Astrolab Interstellar
Rocket Lime Live Rosin Soda .
About
SSC is a public company incorporated under the Business Corporations Act (
SSC has approximately 76.3 million common shares outstanding (basic), of which approximately 20% are held by insiders. Of SSC's outstanding common shares, approximately 15.7 million (21%) are escrowed pursuant to
Notice on Forward Looking Information
This press release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "will", "estimates", "believes", "intends", "expects", "projected", "approximately" and similar expressions which are intended to identify forward-looking statements. More particularly and without limitation, this press release contains forward looking statements concerning SSC's expected results for Q3 2024, SSC's goals for annualized revenue by 2023 exit, the synergies expected from integrating
The forward-looking statements contained in this press release are made as of the date of this press release, and SSC does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by securities law.
Future Oriented Financial Information
This press release contains future-oriented financial information and financial outlook information (collectively, "FOFI") about gross revenue, adjusted EBITDA and normalized net income of SSC, which are subject to the same assumptions, risk factors, limitations and qualifications as set forth in the above paragraphs. FOFI contained in this document was approved by management as of the date of this document and was provided for the purpose of providing further information about SSC's future business operations. SSC and its management believe that FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments, and represent, to the best of management's knowledge and opinion, the SSC's expected course of action. However, because this information is highly subjective, it should not be relied on as necessarily indicative of future results. SSC disclaims any intention or obligation to update or revise any FOFI contained in this document, whether as a result of new information, future events or otherwise, unless required pursuant to applicable law. Readers are cautioned that the FOFI contained in this document should not be used for purposes other than for which it is disclosed herein. Differences in the timing of capital expenditures or revenues and variances in production estimates can have a significant impact on the key performance measures included in SSC's guidance. SSC's actual results may differ materially from these estimates.
Non-IFRS Financial Measures
This press release includes references to "adjusted EBITDA" and "normalized net income", which are not defined under International Financial Reporting Standards (IFRS). The intent of these non-IFRS measures is to provide additional useful information to investors and analysts. These non-IFRS measures do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other entities. As such, these non-IFRS measures should not be considered in isolation or used as a substitute for measures of performance prepared in accordance with IFRS.
Adjusted EBITDA is calculated as income before interest, taxes, depreciation and amortization expenses. Adjusted EBITDA is considered as a useful measure by management of SSC to understand the profitability of SSC excluding the effects of capital structure, taxation and depreciation, but may not be appropriate for other purposes. Adjusted EBITDA is not defined under IFRS and therefore should not be considered an alternative to, or more meaningful than, income (loss) and comprehensive income (loss).
The following table reconciles net income (loss) to EBITDA:
|
Three months ended |
Six months ended |
||
|
$ |
$ |
$ |
$ |
|
|
|
|
|
Net and comprehensive (loss) income |
1,220,798 |
1,161,241 |
1,723,244 |
1,920,070 |
Add (deduct): |
|
|
|
|
Depreciation and amortization |
13,324 |
11,549 |
26,558 |
22,714 |
Net interest (income) expense |
48,937 |
89,040 |
100,769 |
195,344 |
EBITDA |
1,282,969 |
1,261,830 |
1,850,571 |
2,138,128 |
The following table reconciles net income (loss) to Adjusted EBITDA:
|
Three months ended |
Six months ended |
||
|
$ |
$ |
$ |
$ |
|
|
|
|
|
Net and comprehensive (loss) income |
1,220,798 |
1,161,241 |
1,723,244 |
1,920,070 |
Add (deduct): |
|
|
|
|
Depreciation and amortization |
13,324 |
11,549 |
26,558 |
22,714 |
Net interest (income) expense |
48,937 |
89,040 |
100,769 |
195,344 |
Gain on settlement |
(431,671) |
- |
(431,671) |
- |
Gain on disposal |
- |
(353,833) |
- |
(353,833) |
Share compensation expense |
101,688 |
30,063 |
145,657 |
112,576 |
Adjusted EBITDA |
952,986 |
938,060 |
1,564,557 |
1,896,871 |
Normalized net income is calculated as net income less any gain settlement or disposal, plus the share compensation expense. Normalized Net Income is considered as a useful measure by management of SSC to understand the profitability of SSC excluding the effects of certain non-operating items.
The following table reconciles net income (loss) to Normalized Net Income:
|
Three months ended |
Six months ended |
||
|
$ |
$ |
$ |
$ |
|
|
|
|
|
Net and comprehensive (loss) income |
1,220,798 |
1,161,241 |
1,723,244 |
1,920,070 |
Add (deduct): |
|
|
|
|
Gain on settlement |
(431,671) |
- |
(431,671) |
- |
Gain on disposal |
- |
(353,833) |
- |
(353,833) |
Share compensation expense |
101,688 |
30,063 |
145,657 |
112,576 |
Normalized Net Income |
890,815 |
837,471 |
1,437,230 |
1,678,813 |
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.
Neither
SOURCE